Medplus Subsidiary's Store Receives Drug License Suspension Order in Nashik
Medplus Health Services Limited has reported that its subsidiary, Optival Health Solutions Private Limited, received an order resulting in the suspension of a drug license for one of its stores located in Maharashtra.The action was initiated by the Asst. Commissioner & Licensing authority, Food & Drug Administrations, Nashik Maharashtra. The order was received on July 4, 2026, concerning a store situated at Samta Nagar Nashik Maharashtra.
The suspension involves the seizure and licensing of drugs and cosmetics as per Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The authority ordered the suspension of the Drug License for five days.
Key details regarding the action are presented below:
| Aspect | Details |
|---|---|
| Authority | Asst. Commissioner & Licensing authority, Food & Drug Administrations, Nashik Maharashtra |
| Nature of Action | Suspension of Drug License for a store located in Samta Nagar Nashik Maharashtra |
| Date of Order Receipt | 04.07.2026 |
| Alleged Violation | Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 |
| Financial Impact | Potential Revenue Loss of Rs 0.75 lacs |
MEDPLUS Stock Price Movement
On Friday, Medplus Health Services Limited shares edged higher, settling at ₹822 after gaining 0.97%. The equity traded on a volume of 79,307 shares, as its daily trading range reached a high of ₹825.6.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.